Kimberly A Brown, Mhs|Kimberly A Mencarini, Kimberly Brown, Kimberly Mencarini

Kimberly A Brown, Mhs|Kimberly A Mencarini, Kimberly Brown, Kimberly Mencarini

Jazz Pharmaceuticals - / Ireland
Others
AD Scientific Index ID: 5601951
person_outline Kimberly A Brown, Mhs|Kimberly A Mencarini, Kimberly Brown, Kimberly Mencarini's MOST POPULAR ARTICLES
1-) Early hepatitis B virus DNA reduction in hepatitis B e antigen–positive patients with chronic hepatitis B: A randomized international study of entecavir versus adefovirN Leung, CY Peng, HW Hann, J Sollano, J Lao‐Tan, CW Hsu, L Lesmana, ...Hepatology 49 (1), 72-79, 20092292009
2-) Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis BR Perrillo, M Buti, F Durand, M Charlton, A Gadano, G Cantisani, ...Liver Transplantation 19 (8), 887-895, 2013642013
3-) Peginterferon-α-2b and ribavirin for hepatitis C recurrence postorthotopic liver transplantationFD Gordon, P Kwo, R Ghalib, J Crippin, HE Vargas, KA Brown, T Schiano, ...Journal of clinical gastroenterology 46 (8), 700-708, 2012232012
4-) 998 ENTECAVIR (ETV) RESULTS IN HIGHER HBV DNA REDUCTION VERSUS ADEFOVIR (ADV) IN ANTIVIRAL-NAIVE HBEAG (+) ADULTS WITH HIGH HBVDNA: WEEK 96 RESULTS (EARLY STUDY)N Leung, CY Peng, J Sollano, L Lesmana, MF Yuen, L Jeffers, HW Hann, ...Journal of Hepatology, S373-S374, 2008132008
5-) Probability of sustained virologic response (SVR) is associated with the magnitude of HCV RNA reduction at week 4 of treatment with peginterferon (PEG) plus ribavirin (RBV …M Sulkowski, JM Vierling, KA Brown, SL Flamm, P Kwo, KD Mullen, ...Hepatology 48 (Suppl 4), A1868, 2008112008